PASITHEA THERAPEUTICS CORP. Stock Issued During Period, Shares, Acquisitions
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- PASITHEA THERAPEUTICS CORP. stock issued during period, shares, acquisitions for fiscal 2023 was 135.00K shares, a 17.20% decline from fiscal 2022.
- PASITHEA THERAPEUTICS CORP. stock issued during period, shares, acquisitions for fiscal 2022 was 163.04K shares.
| Period end | Stock Issued During Period, Shares, Acquisitions 3 month | Stock Issued During Period, Shares, Acquisitions 12 month |
|---|---|---|
| 2023-12-31 | 135.00K shares 10-K · filed 2024-03-29 | |
| 2022-12-31 | 163.04K shares 10-K · filed 2024-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Rocket One Inc. (RKTO) | United States | $0.019B |